| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 03/12/1997 | CN1145074A Carbamoylmethylurea derivative |
| 03/12/1997 | CN1145072A Improved process for making D-(+)- biotine intermediate product |
| 03/12/1997 | CN1145071A Heterocyclic compounds and their preparation and use |
| 03/12/1997 | CN1145067A Anti-helicombacter ester and carbamate derivatives of azolones |
| 03/12/1997 | CN1145066A Aminostilbazole derivative and medicine |
| 03/12/1997 | CN1145031A Starch-metal complexes for skin and hair |
| 03/12/1997 | CN1145030A Halofantrine free base for the treatment of malaria and compositions |
| 03/12/1997 | CN1145029A Use of xanthine derivatives for reducing the pathological hyper-reactivity of eosinophilic granulocytes, novel xanthine compounds and process for producing them |
| 03/12/1997 | CN1145028A A improved method of synthesis for 6,9-bis|(2-aminoethyl)amino¨ benzo|g¨ isoquinoline-5,10-dione and its dimaleate salt |
| 03/12/1997 | CN1145027A Use of insulin sensitisers for treating renal diseases |
| 03/12/1997 | CN1144805A Prodrugs of paclitaxel derivatives |
| 03/12/1997 | CN1144802A Pyridazinone derivatives and processes for preparing the same |
| 03/12/1997 | CN1144801A Beta-Adrenergic agonists |
| 03/12/1997 | CN1144800A 3-substituted oxindole derivatives as potassium channel modulators |
| 03/12/1997 | CN1144690A Keep-clean agent and its moist-retaining tissues |
| 03/12/1997 | CN1144658A Zhuling polysaccharide powder injection and its preparation method |
| 03/12/1997 | CN1144657A Artificial snake bile and its manufacture method and usage |
| 03/12/1997 | CN1144656A Pharmaceutical compositions containing irbesartan |
| 03/12/1997 | CN1144655A Indomethacin adhesive plaster |
| 03/12/1997 | CN1034217C Anti-proliferative and anti-inflammatory compounds:derivatives of pentose monosaccharides |
| 03/12/1997 | CN1034216C 7-(substituted)-9-|(substituted glycyl) amido¨-6-demethyl-6-deoxytetracyclines |
| 03/11/1997 | US5610320 Antitumor agents |
| 03/11/1997 | US5610319 Compound useful as antiproliferative agents and GARFT inhibitors |
| 03/11/1997 | US5610310 Cyclic lipid derivatives as potent PAF antagonists |
| 03/11/1997 | US5610304 Pyrimidinyl or pyridinyl sulfonamide substituted compounds |
| 03/11/1997 | US5610303 Monoamide oxidase inhibitors |
| 03/11/1997 | US5610302 Composition intended for use for retarding hair loss and for inducing and stimulating its growth, containing 2-aminopyrimidine 3-oxide derivatives, and new compounds derived from 2-aminopyrimidine 3-oxide |
| 03/11/1997 | US5610300 Carbocyclic nucleosides containing bicyclic rings, oligonucleotides therefrom, process for their preparation, their use and intermediates |
| 03/11/1997 | US5610296 Chemical intermediates of antithrombotics |
| 03/11/1997 | US5610295 4-amino-2-(hetero)aryl-butanamides useful as 5-HT1A -antagonists |
| 03/11/1997 | US5610294 Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors |
| 03/11/1997 | US5610293 Methods of preparing manganese complexes of nitrogen-containing macrocyclic ligands |
| 03/11/1997 | US5610271 Kappa receptor selective opioid peptides |
| 03/11/1997 | US5610200 Anhydroretinol and derivatives thereof as antagonists of immune responses and inhibitors of cancer cell growth |
| 03/11/1997 | US5610198 Anti-mycobacterial compositions and their use for the treatment of tuberculosis and related diseases |
| 03/11/1997 | US5610196 Methyl unsaturated long-chain alkyl ketone, acne |
| 03/11/1997 | US5610195 Ornithine decarboxylase inhibiting branched aminooxy amino alkane derivatives |
| 03/11/1997 | US5610193 Pharmaceutical composition |
| 03/11/1997 | US5610192 Inhibitors of metazoan parasite proteases |
| 03/11/1997 | US5610190 Retroviral protease inhibitors |
| 03/11/1997 | US5610185 Method for the treatment of hyperproliferative epithelial skin diseases by topical application of hydroxylated aromatic protein cross-linking compounds |
| 03/11/1997 | US5610184 Method for sustained and extended corneal analgesia |
| 03/11/1997 | US5610183 Phenylglycine derivatives pharmaceutical compositions containing them and their use in therapy |
| 03/11/1997 | US5610182 Administering an isocarbacyclin of specific structure in the form of a fat emulsion |
| 03/11/1997 | US5610180 Ionizable congeners of aromatic and aliphatic alcohols as anti-leukemia agents |
| 03/11/1997 | US5610179 Method of treating babesiosis |
| 03/11/1997 | US5610178 Macrolides and the use thereof |
| 03/11/1997 | US5610176 Tachykinin (NK1) receptor antagonists |
| 03/11/1997 | US5610175 9-Substituted porphycenes |
| 03/11/1997 | US5610174 Use of α1A -selective adrenoceptor agonists for the treatment of urinary incontinence |
| 03/11/1997 | US5610173 Formulations for lipophilic compounds |
| 03/11/1997 | US5610172 Sulfonamidocarbonylpyridine-2-carboxamides and pyridine-n-oxides which are useful as pharmaceuticals |
| 03/11/1997 | US5610171 Inhibition of metastasis in patients having cancer with pyridyloxazole-2-ones |
| 03/11/1997 | US5610169 Pharmaceutical Composition containing slightly water-soluble drug |
| 03/11/1997 | US5610168 Methods of use for inhibiting bone loss and lowering serum cholesterol |
| 03/11/1997 | US5610167 Methods of inhibiting atrophy of the skin and vagina |
| 03/11/1997 | US5610166 Methods for inhibiting angiogenesis |
| 03/11/1997 | US5610162 Ester derivatives of 4-aza-steroids |
| 03/11/1997 | US5610161 1-azaspiroalkane derivatives; antidepressants, anxiolytic agents; eating disorders |
| 03/11/1997 | US5610160 Topical 5-fluorouracil prodrug composition and method |
| 03/11/1997 | US5610158 Anxiolytic agents, sedatives |
| 03/11/1997 | US5610157 N-(3-hydroxy-4-piperidinyl) (dihydrobenzofuran, dihydro-2H-benzopyran or dihydrobenzo-dioxin) carboxamide derivatives |
| 03/11/1997 | US5610156 Tricyclic benzazepine vasopressin antagonists |
| 03/11/1997 | US5610154 Bicyclic carboxamides |
| 03/11/1997 | US5610153 Benzazepinone derivatives |
| 03/11/1997 | US5610152 Anti-obesity agent 4-cholesten-3-one |
| 03/11/1997 | US5610151 Monomeric bile acid derivatives, processes for their preparation and the use of these compounds as medicaments |
| 03/11/1997 | US5610150 Prostate cancer, enzyme inhibitors |
| 03/11/1997 | US5610146 2,3-disubstituted isoxazolidines, a process for their preparation, agents containing them, and their use |
| 03/11/1997 | US5610144 Pyrrolidine and thiazolidine derivatives, their preparation and medicaments containing them |
| 03/11/1997 | US5610139 Peptide from horseshoe crab extract, antibiotic, staphylococcus |
| 03/11/1997 | US5610136 Administering chorionic gonadotropin |
| 03/11/1997 | US5610134 Treatment of congestive heart failure |
| 03/11/1997 | US5610047 Trehalose |
| 03/11/1997 | US5610011 Virulence-encoding DNA sequences of Strepococcus suis and related products and methods |
| 03/11/1997 | US5609884 Controlled release naproxen sodium plus naproxen combination tablet |
| 03/11/1997 | US5609882 Antitumor |
| 03/11/1997 | US5609878 Adsorbent polymer |
| 03/11/1997 | US5609877 Treatment of the articular symptoms of rheumatoid arthritis |
| 03/11/1997 | US5609874 Method of treating viral infections |
| 03/11/1997 | US5609867 Polymeric antitumor agents |
| 03/11/1997 | US5609866 Polyvinylpyrrolidone-iodine, nonionic surfactant |
| 03/11/1997 | US5609864 Polyvinylpyrrolidone iodine |
| 03/11/1997 | CA2109435C Compositions of n-(phosphonoacetyl)-l-aspartic acid and methods of their use as broad spectrum antivirals |
| 03/11/1997 | CA2015505C Polyamines and polypeptides useful as antagonists of excitatory amino acid neurotransmitters and/or as blockers of calcium channels |
| 03/09/1997 | CA2184887A1 Pharmaceutical combination preparation comprising ketoprofen |
| 03/09/1997 | CA2184783A1 Nonclassical antifolates |
| 03/07/1997 | CA2184881A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiinflammatory activity prepared therefrom |
| 03/06/1997 | WO1997008334A1 Cryptophycins from aberrant biosynthesis |
| 03/06/1997 | WO1997008321A1 Asthma associated factors as targets for treating atopic allergies including asthma and related disorders |
| 03/06/1997 | WO1997008319A1 Genetic alterations related to familial alzheimer's disease |
| 03/06/1997 | WO1997008311A1 Novel procollagens |
| 03/06/1997 | WO1997008310A1 Novel 3' terminal sequence of hepatitis c virus genome and diagnostic and therapeutic uses thereof |
| 03/06/1997 | WO1997008300A1 Crystalline zap family proteins |
| 03/06/1997 | WO1997008249A1 Acid resistant calcium carbonate composition containing an aluminum salt and uses therefor |
| 03/06/1997 | WO1997008207A1 Fluorinated sialyl-lewis x derivatives and intermediates for synthesis thereof |
| 03/06/1997 | WO1997008202A1 Antisecretory factor peptides regulating pathological permeability changes |
| 03/06/1997 | WO1997008201A1 Autoantibodies in patients with acquired hypoparathyroidism and assay method therefor |
| 03/06/1997 | WO1997008199A2 Antimicrobial cationic peptides and methods of screening for the same |
| 03/06/1997 | WO1997008196A1 Neurturin and related growth factors |